par Journé, Fabrice 
;Id Boufker, Hichame ;van Kempen, Luc;Galibert, M-D;Wiedig, Murielle;Sales, François ;Theunis, Anne;Nonclercq, Denis;Frau, A;Laurent, Guy ;Awada, Ahmad ;Ghanem, Ghanem Elias
Référence British Journal of Cancer, 105, 11, page (1726-1732)
Publication Publié, 2011-11
;Id Boufker, Hichame ;van Kempen, Luc;Galibert, M-D;Wiedig, Murielle;Sales, François ;Theunis, Anne;Nonclercq, Denis;Frau, A;Laurent, Guy ;Awada, Ahmad ;Ghanem, Ghanem Elias Référence British Journal of Cancer, 105, 11, page (1726-1732)
Publication Publié, 2011-11
Article révisé par les pairs
| Résumé : | Clinical outcome of patients with high-risk melanoma cannot be reliably predicted on the basis of classical histopathological examination. Our study aimed to determine in melanoma metastases a gene expression profile associated with patient survival, and to identify and validate marker(s) of poor clinical outcome. |
